Friday, 25 January 2008
February 8, 2008. GWU & KEI Workshop on Medical Innovation Prize Fund
The GWU-KEI workshop on the Medical Innovation Prize Fund will be a one-day meeting held on February 8, 2008 at the Law School of George Washington University (GWU), co-sponsored by GWU Law School and Knowledge Ecology International (KEI). The workshop will be open to the public and with no fee to attend.
The objective of this workshop is to bring together policy makers and experts to debate proposals to use prizes rather than exclusive marketing rights as the main mechanism to stimulate private investments in medical R&D, with a special focus on Senator Sanders Bill, S.2210 the Medical Innovation Prize Fund Act of 2007.
A description of the bill, links to the text, and views of 16 experts are available here .
At present, the agenda (5Feb08) looks like this:
Agenda GWU – KEI Workshop on Prizes
Working title: Medical Innovation Prize Fund: New paradigm for drug development, or unworkable scheme?
Date of Workshop: February 8, 2008
Venue: George Washington University Law School / L101 – Jacob Burns Moot Court Map
Ground Floor 2000 H Street NW (nearest metro: Foggy Bottom).
9:00 AM – Introduction
John Duffy (GWU/Bio) and James Love (KEI/Bio )
9:30 AM to 11:00 AM – Medical Innovation Prizes and the Proposed Medical Innovation Prize Fund Act, S.2210
Moderator: Christopher Murray, Senior Counsel, Consumer Union
David Reynolds, Senior Health Policy Advisor, Senator Sanders (I-VT)
Ed Mierzwinski, Consumer Program Director, U.S. PIRG (Bio )
John Erickson, CEO, Sequoia Pharmaceuticals (Bio)
Philip S. Johnson, Chief Patent Counsel, Johnson and Johnson
11 AM to 11:15 AM – break
11:15 AM to 1 PM – Valuation of Prizes for drug development
Moderator: Todd Stein, Representative Tom Allen (D-ME)
Aidan Hollis, University of Calgary (Bio) Problems & possibilities in making prizes depend on health impact
Alex Tabarrok, George Mason University (Bio)
James Love, Director, Knowledge Ecology International (Bio)
John E. Calfee, Resident Scholar, American Enterprise Institute (Bio)
1 PM to 2 PM – Lunch (by invitation)
2 PM to 3:30 PM – Management of Prizes
Moderator: Lindsay McAllister, Representative Jan Schakowsky (D-IL)
Michael Abramowicz, George Washington University (Bio)
Sean Flynn, American University (Bio), "TRIPS and Prizes"
Merrill Goozner, Center for Science in the Public Interest (Bio), "How will prizes impact innovation?"
Steve Merrill, Executive Director, NAS STEP Board (Bio), "Lessons from innovation prizes in other fields"
3:30 PM to 3:45 PM – Break
3.45 PM – Open Discussion, For and Against the Medical Innovation Prize Fund
Moderators: John F. Duffy, GWU and James Love, KEI
5:30 PM – Closing remarks
Recommended Readings
- U.S. Senator Sanders Bill S. 2210 The Medical Innovation Prize Fund Act of 2007. Experts Comments
- KEI Research Note 2008:1. Selected Innovation Prizes and Reward Programs (2008)
- Love, J & Hubbard, T. The Big Idea: Prizes to Stimulate R&D for New Medicines. Chicago-Kent Law Review, Volume 82, Number 3 (2007)
- Hollis, A. Incentive Mechanisms for Innovation. Institute for Advanced Policy Research Technical Paper TP-07005 (2007)
- Goozner, M. The Pharmaceutical Innovation Conundrum. GoozNews (2007)
- Wei, M. Should Prizes Replace patents? A critique of the Medical Innovation Prize Act of 2005 . Boston University Journal of Science and Technology Law (2007)
- Erren, T. Prizes to Solve Problems in and beyond Medicine, Big and Small: It Can Work. Medical Hypotheses 68, 732-734 (2007)
- Stiglitz, J. Scrooge and Intellectual Property Rights: A medical medical prize fund could improve the financing of drug innovations . British Medical Journal. 333:1279-80 (2006)
- Goozner, M. Innovation in Biomedicine: Can Stem Cell Research Lead the Way to Affordability?. PLoS Medicine Vol. 3, No. 5, e126 doi:10.1371/journal.pmed.0030126 (2006)
- Duffy, J. The Marginal Cost Controversy in Intellectual Property. University of Chicago Law Review, Vol. 71, No. 1 (2004)
- Abramowicz, M. Perfecting Patent Prizes . Vanderbilt Law Review. 56: 114-236 (2003). Originally George Mason Law & Economics Research Paper No. 01-29 (2001)